Literature DB >> 2832502

Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary.

F E Estivariz1, M I Morano, M Carino, S Jackson, P J Lowry.   

Abstract

In order to investigate the role of N-terminal proopiomelanocortin (N-POMC) in adrenal regeneration after bilateral adrenal enucleation (hereafter referred to as enucleation) rats 13 days after enucleation were injected (200 microliters s.c. plus 200 microliters i.p.) at 08.00 and 20.00 h with normal rabbit serum (NRS), an ACTH antiserum or an N-POMC antiserum. On the next day the animals were injected with colchicine, killed and mitotic figures in adrenal histological sections counted. The same treatment was given to rats 20 days after enucleation. Only the N-POMC antiserum significantly diminished adrenal mitotic activity 14 and 21 days after enucleation (P less than 0.01 and 0.05 respectively) when compared with NRS-treated enucleated rats, whereas plasma corticosterone levels in rats 14 days after enucleation were significantly (P less than 0.005) decreased only by treatment with ACTH antiserum. To determine whether the mitogenic N-POMC peptides involved in adrenal regeneration originated from the pituitary intermediate lobe, 0.9% (w/v) NaCl or ergocryptine (10 mg/kg body weight) was administered s.c. twice daily to rats between 7 and 13 days after enucleation. On day 14, adrenal mitotic activity and plasma levels of ACTH and N-POMC were not significantly different between ergocryptine and saline-treated enucleated rats, whereas alpha-MSH levels in ergocryptine-treated enucleated rats were significantly (P less than 0.02) decreased. Increases in N-POMC content of the pituitary lobe accompanied those of ACTH in animals 7, 10, 14 and 21 days after enucleation (P less than 0.01 compared with sham-treatment). Anterior lobes from rats 10 days after enucleation or from adrenalectomized rats showed raised ACTH and N-POMC levels compared with sham-treated animals, whereas alpha-MSH content in the anterior lobe of enucleated rats was significantly (P less than 0.005) decreased. Adrenalectomized animals had raised (P less than 0.005) amounts of alpha-MSH compared with sham-treated animals. Plasma levels of ACTH and N-POMC were significantly (P less than 0.01) raised in rats 10 days after enucleation or in adrenalectomized rats compared with those in sham-treated animals, whereas alpha-MSH levels were raised (P less than 0.005) only in adrenalectomized rats. Sephadex G-75 chromatography of anterior lobe extracts obtained 10 days after surgery from sham-treated, enucleated and adrenalectomized rats was performed.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832502     DOI: 10.1677/joe.0.1160207

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

Review 1.  The Jeremiah Metzger Lecture. From POMC to functional diversity of neural peptides: the key importance of convertases.

Authors:  M Chretien; L Gasper; S Benjannet; M Mbikay; C Lazure; N G Seidah
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

2.  Bilateral adrenal enucleation-induced changes in adenohypophyseal pro-opiomelanocortin (POMC)-related peptides synthesis and secretion: a comparative study with adrenalectomized rats.

Authors:  M J Perone; A N Chisari; C L Gómez Dumm; E Spinedi; F E Estivariz
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 3.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

4.  Transplantation of adrenal cortical progenitor cells enriched by Nile red.

Authors:  James C Y Dunn; Yinting Chu; Harry H Qin; Tatiana Zupekan
Journal:  J Surg Res       Date:  2009-05-14       Impact factor: 2.192

5.  Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production.

Authors:  Anthony P Coll; Martin Fassnacht; Steffen Klammer; Stephanie Hahner; Dominik M Schulte; Sarah Piper; Y C Loraine Tung; Benjamin G Challis; Yacob Weinstein; Bruno Allolio; Stephen O'Rahilly; Felix Beuschlein
Journal:  J Endocrinol       Date:  2006-08       Impact factor: 4.286

6.  Enucleation-induced rat adrenal gland regeneration: expression profile of selected genes involved in control of adrenocortical cell proliferation.

Authors:  Marianna Tyczewska; Marcin Rucinski; Agnieszka Ziolkowska; Marta Szyszka; Marcin Trejter; Anna Hochol-Molenda; Krzysztof W Nowak; Ludwik K Malendowicz
Journal:  Int J Endocrinol       Date:  2014-11-06       Impact factor: 3.257

Review 7.  Functional Zonation of the Adult Mammalian Adrenal Cortex.

Authors:  Gavin P Vinson
Journal:  Front Neurosci       Date:  2016-06-15       Impact factor: 4.677

Review 8.  FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.

Authors:  Mariangela Tamburello; Barbara Altieri; Iuliu Sbiera; Sandra Sigala; Alfredo Berruti; Martin Fassnacht; Silviu Sbiera
Journal:  Endocrine       Date:  2022-05-18       Impact factor: 3.925

Review 9.  The human adrenal cortex: growth control and disorders.

Authors:  Claudimara Ferini Pacicco Lotfi; Jean Lucas Kremer; Barbara Dos Santos Passaia; Isadora Pontes Cavalcante
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.